Clinical trial to discover effects of infusing young plasma in adults
A California-based company is letting people to enroll in the first US clinical trial that aims to find out what happens when the veins of adults are filled with the blood of young people. The start-up Ambrosia’s founder Jesse Karmazin hopes to use blood transfusions as a means to fight aging.
Blood transfusions have been deemed as one of the safest life-saving procedures for a person has undergone a major surgery or been in a serious accident. But there is still no credible evidence whether they can be linked to even a single health benefit in people. The trial offered by Ambrosia requires participants to pay $8,000 to get 1.5 litres of plasma from a donor between the ages of 16 and 25 over the course of two days.
A description registered on ClinicalTrials.gov says that Karmazin wants to enroll 600 people for the trial. He will be conducting it with physician David Wright who owns a private intravenous-therapy centre in Monterey. The participants’ blood will be tested for biomarkers both before and after the infusion is carried out.
